Trials / Unknown
UnknownNCT00834301
An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Nephrian · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine whether an ingestion of a new renal multivitamin supplement can have a beneficial effect on bone and mineral adn inflammation issues related to patients on dialysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Oral Multivitamin | Oral Multivitamin |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2009-02-03
- Last updated
- 2009-02-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00834301. Inclusion in this directory is not an endorsement.